Clarithromycin in Multiple Myeloma Induction Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients
- Status
- UNKNOWN
- Phase
- NA
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
- Status
- UNKNOWN
- Phase
- PHASE2
An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
- Status
- COMPLETED
- Phase
- N/A
Modified Bortezomib-based Combination Therapy for Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE4
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
- Status
- COMPLETED
- Phase
- N/A
Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CART-BCMA Cells for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide.
- Status
- COMPLETED
- Phase
- N/A
A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE3